Mark Crossley
Chief Executive Officer at INDIVIOR PLC
Net worth: 2 M $ as of 2024-03-30
Network origin in Mark Crossley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
42
| Public Company | Pharmaceuticals: Major | 42 |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Crossley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
The Royal Horticultural Society
 The Royal Horticultural Society Miscellaneous Commercial ServicesCommercial Services The Royal Horticultural Society promotes horticulture for the benefit of local people and the environment. The non-profit company is based in London, UK and has subsidiaries in United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IKARIA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| ADIAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director of Finance/CFO Public Communications Contact | |
| KINGFISHER PLC | Home Improvement Chains | Corporate Secretary | |
| BURBERRY GROUP PLC | Apparel/Footwear | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Bryn Mawr College | College/University | Doctorate Degree | |
| Colgate University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Graduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| Medical College of Virginia | College/University | Corporate Officer/Principal | |
| Office of National Drug Control Policy | General Government | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Lincoln | College/University | Masters Business Admin | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
Treatment Research Institute
 Treatment Research Institute Miscellaneous Commercial ServicesCommercial Services Treatment Research Institute provides health, education, research, and planning services. It offers products for clinicians, courts, customer portal, and assessment and evaluation. The company was founded by A. Thomas McLellan in 1992 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Place2Be
 Place2Be Investment Trusts/Mutual FundsMiscellaneous Place2Be is a non-profit organization which provides emotional and therapeutic services in primary and secondary schools. It helps pupils to cope with often social issues including bullying, bereavement, domestic violence, family breakdown, neglect, and trauma. The company was founded by Dame Benita Refson in 1994 and is headquartered in London, the United Kingdom. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
| Hazelden Betty Ford Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Recover Together, Inc.
 Recover Together, Inc. Medical/Nursing ServicesHealth Services Recover Together, Inc. engages in provision of treatment to recover from opiate use. It specializes in opiate addiction treatment, Suboxone buprenorphine, and group therapy. The company was founded by Jeff De Flavio, Joy Sun and Silas Howland in 2015 and is headquartered in Nashville, TN. | Medical/Nursing Services | Director/Board Member | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Chairman | |
Reckitt Benckiser Health Ltd.
 Reckitt Benckiser Health Ltd. Medical DistributorsDistribution Services Founded in 2017, Reckitt Benckiser Health Ltd. is a subsidiary of Reckitt Benckiser Group Plc. The private company is based in Slough, UK. Reckitt Benckiser Health is home to the world's most loved and trusted hygiene, health, and nutrition brands. | Medical Distributors | Director/Board Member Director/Board Member | |
| Apterna Ltd. | Director/Board Member | ||
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman |
Statistics
International
| United States | 20 |
| United Kingdom | 20 |
| Ireland | 2 |
| Germany | 2 |
| India | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 3 |
| Consumer Non-Durables | 3 |
Operational
| Director/Board Member | 186 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 69 |
| Undergraduate Degree | 25 |
| Chairman | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Adrian Hennah | 28 |
| Howard H. Pien | 27 |
| Lizabeth Zlatkus | 23 |
| Juliet Thompson | 22 |
| Cary Claiborne | 19 |
| Peter Bains | 19 |
| Barbara Ryan | 18 |
| Daniel Phelan | 17 |
| Christian Schade | 16 |
| Daniel Tassé | 16 |
| Yvonne Greenstreet | 15 |
| Rupert Bondy | 14 |
| Lorna Parker | 13 |
| Jerome Lande | 13 |
| Joanna Le Couilliard | 12 |
- Stock Market
- Insiders
- Mark Crossley
- Company connections
